ClinicalTrials.gg
Status unknownNCT05881954Updated May 31, 2023

Outcomes of Natives and Graft-related Femoral Reconstruction With Tubulized Pericardial Patchs

An observational study in Vascular Complications, sponsored by University Paul Sabatier of Toulouse. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-05-31.

Sponsored by University Paul Sabatier of Toulouse · Observational

The sponsor has not verified this record recently (last verified May 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
20
Ages
18 Years and older
Sex
All
01

Study summary

Groin wound infection after arterial femoral prosthetic reconstruction or percutaneous access and drug abusers are frequent and increase largely the post operative morbi-mortality.

There is no perfect substitute to replace infected graft or to restaure femoral artery in septic condition moreover when all the femoral bifurcation is involved with a femoro-femoral bypass mandatory.

Seeing the encouraging results of rolled pericardium patch to treat native and prosthetics aortic infections in term of patency and infection resistance, the investigators propose to evaluate the outcomes of this subsitute rolled with samples in case of femoro-femoral repair in septic condition.

Read the detailed description

Groin wound infection after vascular surgery is a frequent complication with a significant increase in post operative morbidity and mortality. Actual studies reported more than 20% of patients who develop groin wound infection with an important rate of reintervention and risk in limb loss. Theses groin complications are frequent in drug abusers but can also happen after percutaneous femoral access for endovascular therapy leading to arterial reconstruction.

After mechanical debridement and eventually muscle flap rotation, ESVS 2020 guidelines recommend in situ reconstruction with the use of autogenous reconstruction vein femoral vein but it is a demanding surgery especially in redo surgery with extensive incision and deep venous complication. Saphenous vein is often too small in diameter to perform a femoro-femoral reconstruction. The other possibility is cryopreserved Cadaveric Arterial Allograft which are difficult to obtain in sufficient time for an urgent operation with frequent aneurysmal evolution. Literature reports up to 30% of reinfection with rifampin-soaked Dacron conduit are used with frequent reintervention. Rolled Bovine pericardium grafts have been proposed as a primary intention substitute in native and prosthetics aortic infections and are presented as resistant to infection when used as patch repair in case of groin complications. The aim of our study was to evaluate the outcomes in term of patency, limb salvage and infection resistance of this substitute when tubulized with stample in groin wound infection to replace previous prosthetic graft with active infection or false aneurysm rupture or after percutaneous septic femoral access complication in emergency surgery.

02

Conditions studied

  • Vascular Complications
03

In context

Lead sponsor

University Paul Sabatier of Toulouse is the lead sponsor of 13 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

Patients presenting a graft infection in the groin or a septic false aneurysm of the femoral artery.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Previous femoral artery reconstruction with infected graft
  • Femoral artery septic false aneurysm needed complete arterial reconstruction (drug abuser or percutaneous femoral access)

Exclusion criteria

Exclusion Criteria:

  • Simple patch closure of femoral artery
  • Groin infection without femoral artery reconstruction Pregnancy Minors
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
20 participants (estimated)
Patient registry
No

Interventions

  • ProcedureGroin infection

    Femoral artery reconstruction with tubulized pericardium patch

06

What researchers measure

Primary outcomes

  1. Patency

    Patency of the bypass

    Time frame: 3 months

  2. Absence of reinfection

    Disparition of infections signs : biological and clinically

    Time frame: After antibiotherapy (6 weeks generally)

Secondary outcomes

  1. Reintervention

    Need of reoperation during the follow up

    Time frame: 30 days post operative; 3 months, 6 months, 12 months

  2. Late patency

    Patency of the Bypass

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • Aurélien Hostalrich [ahostalrich]
    Toulouse, 31059, France
    Recruiting
08

References and documents

Publications

  • Alonso W, Ozdemir B, Chassin-Trubert L, Ziza V, Alric P, Canaud L. Early outcomes of native and graft-related abdominal aortic infection managed with orthotopic xenopericardial grafts. J Vasc Surg. 2021 Jan;73(1):222-231. doi: 10.1016/j.jvs.2020.04.513. Epub 2020 May 20. PubMed 32442610 ↗
  • McMillan WD, Leville CD, Hile CN. Bovine pericardial patch repair in infected fields. J Vasc Surg. 2012 Jun;55(6):1712-5. doi: 10.1016/j.jvs.2011.11.139. Epub 2012 Mar 28. PubMed 22459752 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2020 to primary completion in Jan 2020, 0 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 28, 2023
First posted
May 31, 2023
StartActual
Jan 1, 2020
Primary completionActual
Jan 10, 2020
CompletionEst.
Sep 1, 2023
Last update
May 31, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 31, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05881954
Lead sponsor
University Paul Sabatier of Toulouse
Responsible party
Aurélien Hostalrich (Hostalrich Aurelien, MD, Clinical Professor, University Paul Sabatier of Toulouse) — Principal investigator
First posted
May 31, 2023
Start date
Jan 1, 2020
Primary completion
Jan 10, 2020
Completion
Sep 1, 2023 (estimated)
Last update
May 31, 2023

Study contacts

Aurélien H [ahostalrich]
Contact
hostalrich.a@chu-toulouse.fr
0673303969
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion